12 results
8-K
EX-99.2
SCTL
Societal CDMO Inc
8 Nov 23
Societal CDMO Reports Third Quarter 2023 Financial Results
4:11pm
of the product may vary significantly. The graph does not assume new customer additions or attrition. The information provided is illustrative only … – Est. 2023 (1) Size of Icon Represents 2023 Revenue Value $1 million$15 million $0.5 million Not Risk Adj for Attrition Lannett Teva Advanz
8-K
EX-99.2
SCTL
Societal CDMO Inc
14 Aug 23
Societal CDMO Reports Second Quarter 2023 Financial Results
4:28pm
of the product may vary significantly. The graph does not assume new customer additions or attrition. The information provided is illustrative only … – Est. 2023 (1) Size of Icon Represents 2023 Revenue Value $1 million$15 million $0.5 million Not Risk Adj for Attrition Lannett Teva Advanz Clinical
8-K
EX-99.2
cz1fsk9
10 May 23
Societal CDMO Reports First Quarter 2023 Financial Results
4:22pm
8-K
EX-99.1
4kvpmzl7cl xb44r3c
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-99.1
n1zhi6uq
16 Nov 22
Regulation FD Disclosure
9:24am
8-K
EX-99.1
4l0k7mo9n013a hkz
8 Jun 22
Corporate Presentation May 2022
7:35am
8-K
EX-99.2
585gvurolwzn4he
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.2
wndace6a
1 Mar 22
Recro Reports Fourth Quarter and Year End 2021 Financial Results
4:12pm
8-K
EX-99.2
ma1m6d 45h3zb3it
19 Aug 21
Vida Strategic Partners
9:01am
- Prev
- 1
- Next